Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-06-07T19:43:22.383Z Has data issue: false hasContentIssue false

Sinonasal cancer: an overview of the emerging subtypes

Published online by Cambridge University Press:  12 March 2020

J S Virk
Affiliation:
Department of ENT, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
J Chan
Affiliation:
Barts and the London School of Medicine and Dentistry, London, UK
L Dimitrov*
Affiliation:
Department of ENT, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
A Williamson
Affiliation:
Department of ENT, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
A Sandison
Affiliation:
Histopathology Department, Guy's and St Thomas’ Hospital, London, UK
J Weir
Affiliation:
Department of Histopathology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
P Clarke
Affiliation:
Department of ENT, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK
*
Author for correspondence: Miss Lilia Dimitrov, ENT Department, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK E-mail: lilygdimitrov@gmail.com

Abstract

Background

Advances in immunohistochemistry have spearheaded major developments in our understanding and classification of sinonasal tumours. In the last decade, several new distinct histopathological entities of sinonasal cancer have been characterised.

Objectives

This review aims to provide a clinical update of the major emerging subtypes for the ENT surgeon and an overview of the management strategies available for this heterogeneous group of pathologies.

Conclusion

Although rare, knowledge of sinonasal neoplasm subtypes has implications for prognosis, treatment strategies and the development of novel therapeutic targets.

Type
Review Articles
Copyright
Copyright © JLO (1984) Limited, 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Miss L Dimitrov takes responsibility for the integrity of the content of the paper

References

Sanghvi, S, Khan, MN, Patel, NR, Yeldandi, S, Baredes, S, Eloy, JA. Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients. Laryngoscope 2014;124:7683CrossRefGoogle ScholarPubMed
Stelow, EB, Bishop, JA. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base. Head Neck Pathol 2017;11:315CrossRefGoogle ScholarPubMed
Lewis, JS Jr, Bishop, JA, Gillison, M, Westra, WH, Yarborough, WG. Tumours of the nasal cavity, paranasal sinuses and skull base: carcinomas: sinonasal undifferentiated carcinoma. In: El-Naggar, AK, Chan, JKC, Grandis, JR, Takata, T, Slootweg, PJ, eds. WHO Classification of Head and Neck Tumours. Lyon: IARC, 2017;1820Google Scholar
Agaimy, A, Weichert, W. SMARCA4-deficient sinonasal carcinoma. Head Neck Pathol 2017;11:541–5CrossRefGoogle ScholarPubMed
Masliah-Planchon, J, Bieche, I, Guinebretiere, JM, Bourdeaut, F, Delattre, O. SWI/SNF chromatin remodeling and human malignancies. Annu Rev Pathol 2015;10:145–71CrossRefGoogle ScholarPubMed
Jelinic, P, Mueller, JJ, Olvera, N, Dao, F, Scott, SN, Shah, R et al. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet 2014;46:424–6CrossRefGoogle ScholarPubMed
Herpel, E, Rieker, RJ, Dienemann, H, Muley, T, Meister, M, Harmann, A et al. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol 2017;26:4751CrossRefGoogle ScholarPubMed
Jo, VY, Chau, NG, Hornick, JL, Krane, JF, Sholl, LM. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol 2017;30:650–9CrossRefGoogle ScholarPubMed
Agaimy, A, Koch, M, Lell, M, Semrau, S, Dudek, W, Wachter, WL et al. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol 2014;38:1274–81CrossRefGoogle ScholarPubMed
Bishop, JA, Antonescu, CR, Westra, WH. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol 2014;38:1282–9CrossRefGoogle ScholarPubMed
French, CA, Kutok, JL, Faquin, WC, Toretsky, JA, Antonescu, CR, Griffin, CA et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004;22:4135–9CrossRefGoogle Scholar
French, CA, Miyoshi, I, Kubonishi, I, Grier, HE, Perez-Atayde, AR, Fletcher, JA. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 2003;63:304–7Google ScholarPubMed
Haack, H, Johnson, LA, Fry, CJ, Crosby, K, Polakiewicz, RD, Stelow, EB et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009;33:984–91CrossRefGoogle ScholarPubMed
Lewis, JS Jr, Westra, WH, Thompson, LD, Barnes, L, Cardesa, A, Hunt, JL et al. The sinonasal tract: another potential “hot spot” for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol 2014;8:241–9CrossRefGoogle ScholarPubMed
Bishop, JA, Guo, TW, Smith, DF, Wang, H, Ogawa, T, Pai, SI et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2013;37:185–92CrossRefGoogle ScholarPubMed
Larque, AB, Hakim, S, Ordi, J, Nadal, A, Diaz, A, del Pino, M. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol 2014;27:343–51CrossRefGoogle Scholar
Bishop, JA, Andreasen, S, Hang, JF, Bullock, MJ, Chen, TY, Franchi, A et al. HPV-related multiphenotypic sinonasal carcinoma: an expanded series of 49 cases of the tumor formerly known as HPV-related carcinoma with adenoid cystic carcinoma-like features. Am J Surg Pathol 2017;41:1690–701CrossRefGoogle ScholarPubMed
Bishop, JA. Newly described tumor entities in sinonasal tract pathology. Head Neck Pathol 2016;10:2331CrossRefGoogle ScholarPubMed
Hwang, SJ, Ok, S, Lee, HM, Lee, E, Park, IH. Human papillomavirus-related carcinoma with adenoid cystic-like features of the inferior turbinate: a case report. Auris Nasus Larynx 2015;42:53–5CrossRefGoogle ScholarPubMed
Wang, X, Bledsoe, KL, Graham, RP, Asmann, YW, Viswanatha, DS, Lewis, JE et al. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 2014;46:666–8CrossRefGoogle ScholarPubMed
Lewis, JT, Oliveira, AM, Nascimento, AG, Schembri-Wismayer, D, Moore, EA, Olsen, KD et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol 2012;36:517–25CrossRefGoogle ScholarPubMed
Huang, SC, Ghossein, RA, Bishop, JA, Zhang, L, Chen, TC, Huang, HY et al. Novel PAX3-NCOA1 fusions in biphenotypic sinonasal sarcoma with focal rhabdomyoblastic differentiation. Am J Surg Pathol 2016;40:51–9CrossRefGoogle ScholarPubMed
Zur, KB, Brandwein, M, Wang, B, Som, P, Gordon, R, Urken, ML. Primary description of a new entity, renal cell-like carcinoma of the nasal cavity: van Meegeren in the house of Vermeer. Arch Otolaryngol Head Neck Surg 2002;128:441–7CrossRefGoogle Scholar
Storck, K, Hadi, UM, Simpson, R, Ramer, M, Brandwein-Gensler, M. Sinonasal renal cell-like adenocarcinoma: a report on four patients. Head Neck Pathol 2008;2:7580CrossRefGoogle ScholarPubMed
Fleming, KE, Perez-Ordonez, B, Nasser, JG, Psooy, B, Bullock, MJ. Sinonasal seromucinous hamartoma: a review of the literature and a case report with focal myoepithelial cells. Head Neck Pathol 2012;6:395–9CrossRefGoogle Scholar
Lee, DH, Yoon, TM, Lee, JK, Lim, SC. Seromucinous hamartoma of inferior turbinate: a case report. Medicine (Baltimore) 2018;97:e13022CrossRefGoogle ScholarPubMed
Virk, J, Dixon, L, Madani, G, Clarke, P. Anterior skull base and sinonasal surgery: dilemmas and complexities. In: Gibson, D, Manjaly, J, Tatla, T, eds. Head and Neck Imaging – A Multidisciplinary Team Approach. London: Springer, 2018Google Scholar
Khoury, T, Jang, D, Carrau, R, Ready, N, Barak, I, Hachem, RA. Role of induction chemotherapy in sinonasal malignancies: a systematic review. Int Forum Allergy Rhinol 2019;9:212–19CrossRefGoogle ScholarPubMed
Patil, VM, Joshi, A, Noronha, V, Sharma, V, Zanwar, S, Dhumal, S et al. Neoadjuvant chemotherapy in locally advanced and borderline resectable nonsquamous sinonasal tumors (esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation). Int J Surg Oncol 2016;2016:6923730Google Scholar
Noronha, V, Patil, VM, Joshi, A, Krishna, MV, Dhumal, S, Juvekar, S et al. Induction chemotherapy in technically unresectable locally advanced carcinoma of maxillary sinus. Chemother Res Prac 2014;2014:487872Google ScholarPubMed
Ock, CY, Keam, B, Kim, TM, Han, DH, Won, TB, Lee, SH et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med 2016;31:570–8CrossRefGoogle ScholarPubMed
Lopez-Hernandez, A, Vivanco, B, Franchi, A, Bloemena, E, Cabal, VN, Potes, S et al. Genetic profiling of poorly differentiated sinonasal tumours. Sci Rep 2018;8:3998CrossRefGoogle ScholarPubMed
De Cecco, L, Serafini, MS, Facco, C, Granata, R, Orlandi, E, Fallai, C et al. A functional gene expression analysis in epithelial sinonasal cancer: biology and clinical relevance behind three histological subtypes. Oral Oncol 2019;90:94101CrossRefGoogle ScholarPubMed
van der Laan, TP, Iepsma, R, Witjes, MJ, van der Laan, BF, Plaat, BE, Halmos, GB. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: the importance of differentiation grade in determining treatment strategy. Oral Oncol 2016;63:19CrossRefGoogle ScholarPubMed